Erythropoietin prevents secondary brain injury induced by cortical lesion in mice: Possible involvement of Nrf2 signaling pathway

Annals of Clinical and Laboratory Science

Volumn 41, Issue 1, 2011, Pages 25-32

  Jin, Wei ^a   Kong, Jie ^a   Lu, Tianyu ^a   Wang, Handong ^b   Ni, Hongbin ^a   Wu, Jun ^a   Dai, Yuxiang ^a   Jiang, Jian ^a   Liang, Weibang ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEAD INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL CORTEX; DNA; ERYTHROPOIETIN, RECOMBINANT; HAND STRENGTH; HUMANS; IN SITU NICK-END LABELING; MALE; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NERVOUS SYSTEM DISEASES; NF-E2-RELATED FACTOR 2; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS;

EID: 79951882485     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 2004;24: 133-150. (Pubitemid 38199107)
2. Chesnut RM. The management of severe traumatic brain injury. Emerg Med Clin North Am 1997; 15:581-604. (Pubitemid 27329926)
3. McKee JA, Brewer RP, Macy GE, Borel CO, Reynolds JD, Warner DS. Magnesium neuroprotection is limited in humans with acute brain injury. Neurocrit Care 2005; 2:342-351. (Pubitemid 41112410)
4. Park HK, Fernandez II, Dujovny M, Diaz FG. Experimental animal models of traumatic brain injury: medical and biomechanical mechanism. Crit Rev Neurosurg 1999; 9:44-52.
5. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4-9. (Pubitemid 47072553)
6. Owuor ED, Kong AN. Antioxidant- and oxidant-regulated signal transduction pathways. Biochem Pharmacol 2002;64:765-770. (Pubitemid 35238028)
7. Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005;280:29158-29168. (Pubitemid 41161367)
8. Osburn WO, Wakabayashi N, Misra V, Nilles T, Biswal S, Trush MA, Kensler TW. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys 2006;454:7-15. (Pubitemid 44427746)
9. Yan W, Wang HD, Hu ZG, Wang QF, Yin HX. Activation of Nrf2-ARE pathway in brain after traumatic brain injury. Neurosci Lett 2008;431:150-154.
10. Jin W, Wang HD, Yan W, Zhu L, Hu ZG, Ding YS, Tang K. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma 2009;26:131-138.
11. Ozturk E, Demirbilek S, Kadir But A, Saricicek V, Gulec M, Akyol O, Ozcan Ersoy M. Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:922-927. (Pubitemid 41080113)
12. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 2007;425:177-182. (Pubitemid 47418362)
13. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. PNAS USA 2000;97:10526-10531.
14. Lu D, Mahmood A, Qu C, Goussev A, Schallert T, Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 2005; 22:1011-1017. (Pubitemid 41362067)
15. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E, Cerami A, Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. PNAS USA 2002;99:2258-2263. (Pubitemid 34169048)
16. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. PNAS USA 2001;98:4044-4049. (Pubitemid 32249895)
17. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005;19:2026-2028. (Pubitemid 41759753)
18. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001; 412:641-647. (Pubitemid 32772276)
19. Zhu L, Wang HD, Yu XG, Jin W, Qiao L, Lu TJ, Hu ZL, Zhou J. Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: in vitro and in vivo studies. Brain Res 2009;1289:96-105.
20. Hall ED. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg 1985;62:882-887.
21. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J, Shohami E. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 2005;19:1701-1703. (Pubitemid 41429535)
22. Hellal F, Bonnefont-Rousselot D, Croci N, Palmier B, Plotkine M, Marchand-Verrecchia C. Pattern of cerebral edema and hemorrhage in a mice model of diffuse brain injury. Neurosci Lett 2004;357:21-24. (Pubitemid 38186661)
23. Jin W, Wang HD, Yan W, Xu LZ, Wang XL, Zhao XN, Yang XH, Chen G, Ji Y. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008;2008: 725174, E-pub 2009, Jan 25.
24. Byts N, Siren AL. Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med 2009;1:4.
25. Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, Iacopino DG. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res 2007;1182:99-105. (Pubitemid 350086993)
26. Xiong Y, Mahmood A, Qu C, Kazmi H, Zhang ZG, Noguchi CT, Schallert T, Chopp M. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma 2010;27:205-215.
27. Chen XL, Kunsch C. Induction of cytoprotective genes through Nrf2 antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pham Des 2004;10:879-891. (Pubitemid 38380066)
28. Katavetin P, Inagi R, Miyata T, Shao J, Sassa R, Adler S, Eto N, Kato H, Fujita T, Nangaku M. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007;359: 928-934. (Pubitemid 46946906)
29. Genc K, Egrilmez MY, Genc S. Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SHSY5Y cells. Cell Biochem Funct 2010;28:197-201.
30. Kumral A, Gonenc S, Acikgoz O, Sonmez A, Genc K, Yilmaz O, Gokmen N, Duman N, Ozkan H. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2005;87:15-18. (Pubitemid 40091371)
31. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003;198:971-975. (Pubitemid 37152934)